Trillium Therapeutics (acquired 2013) Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.85M

Trillium Therapeutics (acquired 2013) General Information

Description

Developer of protein therapeutics. The company focuses on immune regulation and cytoprotection.

Contact Information

Formerly Known As
Transplantation Technologies
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 96 Skyway Avenue
  • Toronto, Ontario M9W 4Y9
  • Canada
+1 (416)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 96 Skyway Avenue
  • Toronto, Ontario M9W 4Y9
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trillium Therapeutics (acquired 2013) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 09-Apr-2013 $2.85M Completed Generating Revenue
4. Later Stage VC 12-May-2011 Completed Generating Revenue
3. Later Stage VC 22-May-2009 Completed Generating Revenue
2. Later Stage VC 18-Sep-2008 $12M $25.5M Completed Generating Revenue
1. Early Stage VC (Series A) 05-Feb-2004 $13.5M $13.5M Completed Product Development
To view Trillium Therapeutics (acquired 2013)’s complete valuation and funding history, request access »

Trillium Therapeutics (acquired 2013) Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BDC Capital Growth/Expansion Minority
GrowthWorks Venture Capital Minority
MaRS Investment Accelerator Fund Venture Capital Minority
VenGrowth Asset Management Venture Capital Minority
To view Trillium Therapeutics (acquired 2013)’s complete investors history, request access »

Trillium Therapeutics (acquired 2013) FAQs

  • When was Trillium Therapeutics (acquired 2013) founded?

    Trillium Therapeutics (acquired 2013) was founded in 1996.

  • Where is Trillium Therapeutics (acquired 2013) headquartered?

    Trillium Therapeutics (acquired 2013) is headquartered in Toronto, Canada.

  • What industry is Trillium Therapeutics (acquired 2013) in?

    Trillium Therapeutics (acquired 2013)’s primary industry is Biotechnology.

  • Is Trillium Therapeutics (acquired 2013) a private or public company?

    Trillium Therapeutics (acquired 2013) is a Private company.

  • What is the current valuation of Trillium Therapeutics (acquired 2013)?

    The current valuation of Trillium Therapeutics (acquired 2013) is .

  • What is Trillium Therapeutics (acquired 2013)’s current revenue?

    The current revenue for Trillium Therapeutics (acquired 2013) is .

  • How much funding has Trillium Therapeutics (acquired 2013) raised over time?

    Trillium Therapeutics (acquired 2013) has raised $32.9M.

  • Who are Trillium Therapeutics (acquired 2013)’s investors?

    BDC Capital, GrowthWorks, MaRS Investment Accelerator Fund, and VenGrowth Asset Management have invested in Trillium Therapeutics (acquired 2013).

  • When was Trillium Therapeutics (acquired 2013) acquired?

    Trillium Therapeutics (acquired 2013) was acquired on 09-Apr-2013.

  • Who acquired Trillium Therapeutics (acquired 2013)?

    Trillium Therapeutics (acquired 2013) was acquired by Trillium Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process